Long‐Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin

This case highlights the efficacy of postoperative chemotherapy using paclitaxel and carboplatin in the successful treatment of metastatic ECS.

Authors

Institutions

Publication Details

Journal
Cancer Reports
Published
2025-09-01
DOI
https://doi.org/10.1002/cnr2.70346
Citations
1
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
2.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long‐Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin

Soroush Shahrokh, Kambiz Novin, Mohadeseh Shahin, Farzad Taghizadeh‐Hesary
1 citations
Cancer Reports
Uterine Myomas and Treatments
2.06
article

Long‐Term Complete Remission of Metastatic Endometrial Carcinosarcoma With Radical Surgical Resection and Postoperative Chemotherapy Utilizing Paclitaxel and Carboplatin

Soroush Shahrokh, Kambiz Novin, Mohadeseh Shahin, Farzad Taghizadeh‐Hesary
article en
1 citations

Abstract

This case highlights the efficacy of postoperative chemotherapy using paclitaxel and carboplatin in the successful treatment of metastatic ECS.

Cancer ReportsVol. 8(9)
Texas Tech University (US), Iran University of Medical Sciences (IR), Texas Tech University Health Sciences Center (US)
Openalex Percentile: Top 12%
Uterine Myomas and Treatments
2.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.